EVERSANA™ strengthens global market access and pricing leadership in European expansion
"With additional European expertise, EVERSANA is uniquely positioned to activate niche engagements or full-scale commercial services in and outside the region.
- "With additional European expertise, EVERSANA is uniquely positioned to activate niche engagements or full-scale commercial services in and outside the region.
- "\nDouglas Foerster appointed Senior Vice President, Pricing & Market Access, Europe.A proven European Market Access launch readiness and commercialisation expert, Douglas\'s market access and pricing expertise across a range of therapeutic areas includes neurology, infectious diseases, nephrology, vaccines and rare diseases.
- Charles brings deep expertise in driving digital transformation with life sciences clients around pricing, market access, contracting and patient engagement, as well as Software as a Service (SaaS) solutions.\nMark Mulder appointed Vice President, Commercialisation, Europe.
- Mark joins EVERSANA after successfully developing the commercial strategy and leading market access, marketing and multi-channel sales teams at launch for a German biotech company, CO.DON AG, a specialized leader in cell therapies.